Jürgen Drews
Chairman at Genaissance Pharmaceuticals, Inc.
Jürgen Drews active positions
Companies | Position | Start | End |
---|---|---|---|
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Chairman | - | - |
Career history of Jürgen Drews
Former positions of Jürgen Drews
Companies | Position | Start | End |
---|---|---|---|
MORPHOSYS AG | Director/Board Member | 1997-12-31 | 2012-05-30 |
Independent Dir/Board Member | 1997-12-31 | 2012-05-30 | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Director/Board Member | 1997-12-31 | 2011-05-10 |
AGENNIX AG | Director/Board Member | 2010-06-06 | 2011-03-03 |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | Chairman | - | 2009-12-01 |
Bear Stearns Health Innoventures Management LLC
Bear Stearns Health Innoventures Management LLC Investment ManagersFinance A subsidiary of Bear Stearns Asset Management, Inc., Bear Stearns Health Innoventures Management LLC (BSHI) is a venture capital firm headquartered in New York City. | Private Equity Investor | - | 2007-09-29 |
International Biomedicine Management Partners AG | Chairman | 2000-12-31 | 2000-12-31 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Director/Board Member | 1996-12-31 | - |
Statistics
International
United States | 5 |
Germany | 4 |
Switzerland | 2 |
Operational
Director/Board Member | 4 |
Chairman | 3 |
Private Equity Investor | 1 |
Sectoral
Health Technology | 6 |
Finance | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
MORPHOSYS AG | Health Technology |
Private companies | 7 |
---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Health Technology |
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | Commercial Services |
Bear Stearns Health Innoventures Management LLC
Bear Stearns Health Innoventures Management LLC Investment ManagersFinance A subsidiary of Bear Stearns Asset Management, Inc., Bear Stearns Health Innoventures Management LLC (BSHI) is a venture capital firm headquartered in New York City. | Finance |
International Biomedicine Management Partners AG | Finance |
Agennix AG
Agennix AG BiotechnologyHealth Technology Agennix AG was a pharmaceutical company, which engaged in the development of protein-based drugs for oncology, asthma and wound healing. Its clinical development programs included oral talactoferrin alfa and RGB-286638. The company was founded in 1993 and was headquartered in Heidelberg, Germany. | Health Technology |
- Stock Market
- Insiders
- Jürgen Drews
- Experience